ArticleMalaria journal2025
Performance evaluation of the automated haematology analyzer XN-31 for malaria diagnosis in Plasmodium vivax-dominant regions of Thailand.
Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe innovative automated haematology analyzer XN-31 has demonstrated comparable or, in some settings, superior performance to microscopy and rapid diagnostic tests (RDTs), and good concordance with polymerase chain reaction (PCR) in various endemic areas, particularly where Plasmodium falciparum is prevalent. The XN-31 applies the principle of flow cytometry to measure cell size and nucleic acid content to generate a two-dimensional cytogram in approximately one minute. This technique identifies P. falciparum and other species and provides % parasitaemia (MI-RBC%). This study evaluated the diagnostic performance of the XN-31 in Thailand, where Plasmodium vivax is predominant.
methodsFrom November 2019 to June 2022, 349 patients suspected of having malaria were enrolled at the Hospital for Tropical Medicine, Mahidol University, Bangkok. Blood samples were collected via venipuncture and analysed using the XN-31, thick and thin film microscopy, RDTs, and PCR. The qualitative diagnostic accuracy of the XN-31 for detecting malaria parasites and identifying their species was compared with other methods. The quantitative diagnostic ability of the XN-31 was assessed by correlating the MI-RBC% values with % parasitaemia from thin film microscopy.
resultsAmong the 349 samples, 125 were positive according to thick film microscopy (103 P. vivax, 17 P. falciparum, 3 Plasmodium knowlesi, 1 Plasmodium ovale, and 1 Plasmodium malariae). The XN-31 demonstrated 98.4% sensitivity relative to thick film microscopy as the reference method, outperforming the RDT (88.0%). All XN-31-positive samples were confirmed via PCR. The information on the parasite species, flagged as 'Malaria? (P.f)' or 'Malaria? (others)' by the XN-31, which depicts P. falciparum or other Plasmodium species, respectively, matched 100% with microscopic determination. The quantitative performance of the XN-31 was strongly correlated with that of thin film microscopy (correlation coefficient [r] = 0.903).
conclusionsThis is the first study to confirm the accuracy of the XN-31 for both qualitative and quantitative diagnoses in a malaria-endemic region dominated by P. vivax. The XN-31 is expected to be a useful diagnostic tool in similar endemic regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.